Specifically, we show that isaridin E attenuates LPS-driven inflammatory responses in vascular and pulmonary tissues by disrupting the TLR4/NF-κB signaling cascade, a pivotal pathway in the pathogenesis of sepsis and other inflammatory diseases. Here, TLR4 is linked to Sepsis.